4//SEC Filing
Zaremba Rabourn Amy 4
Accession 0001140361-24-003191
CIK 0001228627other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 6:01 PM ET
Size
7.1 KB
Accession
0001140361-24-003191
Insider Transaction Report
Form 4
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
- Award
Common Stock
2024-01-18+40,000→ 82,658 total - Award
Employee Stock Option (right to buy)
2024-01-18+60,000→ 60,000 totalExercise: $2.77Exp: 2034-01-17→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
- [F2]The option will vest with respect to 15,000 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001832343
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 6:01 PM ET
- Size
- 7.1 KB